Defining the frontiers between antifungal resistance, tolerance and the concept of persistence

Eric Delarze1, Dominique Sanglard1

  • 1Institute of Microbiology, University Hospital Lausanne and University Hospital Center, Rue de Bugnon 48, CH-1011 Lausanne, Switzerland.

Insights

Antifungal tolerance, distinct from resistance, allows fungal pathogens to survive treatment by forming persister cells, potentially leading to relapses. Understanding tolerance mechanisms is crucial for effective antifungal therapy.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Pharmacology

Background:

  • Limited antifungal agents necessitate understanding drug resistance and tolerance.
  • Epidemiological cut-off values aid in distinguishing wild-type from drug-resistant fungal populations.
  • Molecular mechanisms of antifungal resistance are increasingly understood.

Purpose of the Study:

  • To review current knowledge on antifungal tolerance.
  • To explore potential mechanisms driving antifungal tolerance.
  • To evaluate the role of antifungal tolerance in treatment efficacy.

Main Methods:

  • Literature review of antifungal tolerance studies.
  • Analysis of mechanisms underlying fungal tolerance.
  • Evaluation of clinical implications of antifungal tolerance.

Main Results:

  • Antifungal tolerance, occurring at drug concentrations above inhibitory levels, promotes the survival of persister cells.
  • Persister cells can survive antifungal therapy, leading to potential treatment failure and relapse.
  • Mechanisms of antifungal tolerance are less understood than resistance but are critical.

Conclusions:

  • Antifungal tolerance is an under-recognized challenge in treating fungal infections.
  • Further research into tolerance mechanisms is essential for developing more effective antifungal strategies.
  • Addressing tolerance may improve outcomes and prevent relapses in patients with fungal diseases.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
37
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
29
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
95